Try our beta test site
4 studies found for:    20616233 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting VRC 605: A Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults
Condition: HIV Prevention
Intervention: Biological: VRC-HIVMAB075-00-AB
2 Recruiting Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB080-00-AB (VRC01LS), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: Prevention of HIV Infection;   HIV Antibodies;   Monoclonal Antibody, Human;   Neutralizing Antibody
Interventions: Biological: VRC-HIVMAB080-00-AB (VRC01LS);   Biological: VRC-HIVMAB060-00-AB (VRC01)
3 Completed VRC 601: A Phase I, Open-Label, Dose-Escalation Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC HIVMAB060-00-AB (VRC01), With Broad HIV-1 Neutralizing Activity, Administered Intravenously or Subcutaneously to HIV-Infected...
Conditions: HIV-1 Infection;   Neutralizing Antibody;   Monoclonal Antibody;   Viral Load;   HIV Antibodies
Intervention: Biological: VRC-HIVMAB060-00-AB
4 Completed Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB060-00-AB (VRC01), Administered Intravenously or Subcutaneously to Healthy Adults
Conditions: HIV Infection;   Monoclonal Antibody, Human;   HIV Antibodies;   VRC01 Monoclonal Antibody;   Neutralizing Antibody
Intervention: Drug: VRC-HIVMAB060-00-AB

Study has passed its completion date and status has not been verified in more than two years.